Do you have a great idea that you want to make reality? Apply for our accelerator to gain skills and resources necessary to make it a success!
Join the global IMAGINE IF! network of Innovators across 16 branches world wide, competing for the non-dilutive funding.
The participation is free, don’t miss this opportunity and apply now!
The global application deadline is 28th of July 2017.
The IMAGINE IF! is the first truly global competition and accelerator program for science-based ventures*.
The accelerator provides to early stage science startups extensive opportunities: mentorship, the potential to secure non-dilutive capital, free advice from leading professional services companies and rapid networking across the Innovation Forum platform.
We are a non-profit organisation supported by 10,000 innovators. We seek to build connections between academia, industry and policy makers, thereby accelerating the speed of technology adoption for the benefit of the wider society. Find more information about us: http://inno-forum.org/
* startups based on genuine, novel scientific idea which has a significant impact on improving human or animal wellbeing (e.g. new medicines, medical devices, new materials or engineering solutions helping to preserve the natural environment in a balanced state)
Introduction to the Innovation Forum; Dr Daniel Moreno (Head of Marketing and Communication, Global Innovation Forum)
How to apply for ImagineIF Accelerator?; Anastassia Bolotkova (President, Innovation Forum Manchester)
Daniel is a Postdoctoral Research Associate in Manchester Metropolitan University, where he investigates the effects of Ibrutinib, a Bruton's Tyrosine Kinase inhibitor, on platelet and endothelial cells in the context of chronic lymphocytic leukaemia.
Interested in entrepreneurship through leadership and innovation, Daniel has many years of experience working with stakeholders and leading international teams: he was Vice-chairman of the Young European Biotechnology Network, where he was also Chief Communication Officer and an Executive Board member. He has participated in the organisation of many scientific and outreach meetings in the UK, Germany, Switzerland and Spain.
Daniel is also a co-opted committee member of the British Society for Cardiovascular Research, where he is working in stablishing an online presence for the society.
Originally coming from Estonia, Anastassia moved to the UK to pursue a degree in Molecular Biology at the University of Manchester. Throughout the studies, she has completed several summer internships in Estonia, UK and Germany, where she was involved in the cancer research. Her strong interest in science and particularly oncology allowed her to win a scholarship and to complete Masters in Translational Medicine at the same university.
Anastassia has always wanted to work within the pharmaceutical sector and thus, after completing the degrees, She moved into the industry by being a Pharma Analyst at Global Business Intelligence and Safety Screening Scientist at AstraZeneca.
Currently, Anastassia works for a company specialising in the personalised medicine and particularly, the production of cancer immunotherapy for melanoma patients. This is the most challenging and exciting role she has ever had as nothing is more rewarding than the ability to help people to extend their lives and to beat cancer sooner.
Anastassia immensely enjoys writing and therefore, voluntarily produces scientific articles for FastBleep and the news for BioNews. She also likes meeting and communicating with people. In addtion, she enjoys having an active lifestyle and in her free time.
Tuesday, July 18th 2017
18:00 – 19:30 (GMT)
Manchester Metropolitan University Business School, Room BS 3.25